A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
Part of paid clinical trials in Scottsdale, Arizona.
- Sponsor
- Bristol-Myers Squibb
- Study ID
- NCT07011732
- Phase
- PHASE3
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 55 Years - 90 Years
- Healthy Volunteers
- Not accepted
Interventions
- Xanomeline/Trospium Chloride Capsule — DRUGSpecified dose on specified days
- Xanomeline Enteric Capsule — DRUGSpecified dose on specified days
- Placebo — DRUGSpecified dose on specified days
Study Details
The purpose of this study is to evaluate the efficacy and safety of KarXT + KarX-EC in adult participants with agitation related to Alzheimer's Disease.
Key Dates
- Start date
- Jul 10, 2025
- Status verified
- Jun 2026
- Primary completion
- Nov 24, 2028
- Completion
- Dec 8, 2028
Study Design
- Enrollment
- 352 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: KarXT + KarX-EC
- Placebo Comparator: Placebo
Primary Outcome Measure
Change from baseline on the Cohen-Mansfield Agitation Inventory-International Psychogeriatric Association (CMAI-IPA) total score at Week 14 [ Time Frame: At Week 14 ]
Central Contacts
- BMS Clinical Trials Contact Center www.BMSClinicalTrials.com855-907-3286
- First line of the email MUST contain NCT # and Site #.
Locations (40)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Imaging Endpoints | Scottsdale | Arizona | 85258 | Nida Laurin, Site 1619 480-290-1547 |
| Advanced Research Center (ARC) - Anaheim | Anaheim | California | 92805 | Steven Macina, Site 1657 714-999-6688 |
| Local Institution - 1637 | La Jolla | California | 92037 | - |
| The Neurology Group | Pomona | California | 91767 | Sadiq Altamimi, Site 1662 |
| Torrance Clinical Research | Torrance | California | 90505 | Marina Raikhel, Site 1639 310-373-8120 |
| Sunwise Clinical Research | Walnut Creek | California | 94596 | Ira Glick, Site 1651 925-298-5147 |
| Local Institution - 1630 | Colorado Springs | Colorado | 80907 | - |
| Local Institution - 1622 | Maitland | Florida | 32751 | Site 1622 |
| Local Institution - 1631 | Maitland | Florida | 32751 | Site 1631 |
| Local Institution - 1666 | Merritt Island | Florida | 32952 | Site 1666 |
| Hope Research Network - Miami | Miami | Florida | 33166 | Jorge Jorge, Site 1609 786-681-4959 |
| Local Institution - 1602 | Miami | Florida | 33122 | Site 1602 |
| Local Institution - 1604 | Miami | Florida | 33186 | - |
| Local Institution - 1618 | Miami | Florida | 33135 | Site 1618 |
| Local Institution - 1608 | Ocala | Florida | 34471 | Site 1608 |
| Combined Research Orlando (CRO) | Orlando | Florida | 32807 | Eric Carbonell, Site 1635 407-440-4493 |
| Progressive Medical Research | Port Orange | Florida | 32127 | Alexander White, Site 1612 386-304-7070 |
| Local Institution - 1655 | Marrero | Louisiana | 70072 | Site 1655 |
| CBH Health | Gaithersburg | Maryland | 20877 | Elia Acevedo Diaz, Site 1636 301-251-4702 |
| Local Institution - 1663 | Foxborough | Massachusetts | 02035-1309 | Site 1663 |
| Boston Center for Memory | Newton | Massachusetts | 02459 | Paul Solomon, Site 1638 413-281-0577 |
| Mayflower Clinical Research | South Dartmouth | Massachusetts | 02747 | Mushtaque Chachar, Site 1642 508-925-7403 |
| Elixia MA | Springfield | Massachusetts | 01103 | Brittany Perreault, Site 1660 |
| NeuroBehavioral Medicine Group | Bloomfield Hills | Michigan | 48302 | Richard Jackson, Site 1665 412-916-2425 |
| Oakland Medical Research | Troy | Michigan | 48085 | Jay Sandberg, Site 1620 248-687-7412 |
| Redbird Research | Las Vegas | Nevada | 89119 | Jelena Kunovac, Site 1649 760-758-2222 |
| Patient First MD | Middletown | New Jersey | 07748 | Matthew Davis, Site 1647 585-288-0893 |
| Global Medical Institutes LLC; Princeton Medical Institute | Princeton | New Jersey | 08540 | Matthew Adasofunjo, Site 1664 |
| Local Institution - 1610 | Inwood | New York | 11096 | Site 1610 |
| Mid Hudson Medical Research | New Windsor | New York | 12553 | Sashi Makam, Site 1656 845-674-9398 |
| Five Towns Neurology PC -Woodmere - 923 Broadway | Woodmere | New York | 11598-1739 | David Steiner, Site 1658 516-239-1800 |
| Local Institution - 1645 | Woodmere | New York | 11598-1739 | - |
| Local Institution - 1659 | Centerville | Ohio | 45459 | Site 1659 |
| Central States Research | Tulsa | Oklahoma | 74136 | Sarah Land, Site 1640 918-645-5400 |
| Local Institution - 1652 | Columbia | South Carolina | 29205 | - |
| Advanced Neurology Epilepsy and Sleep Center | El Paso | Texas | 79912 | Aamr Herekar, Site 1643 505-903-1715 |
| Wasatch Clinical Research, LLC | Salt Lake City | Utah | 84107 | Albert Jarvi, Site 1641 801-288-0607 |
| The Memory Clinic | Bennington | Vermont | 05201-9810 | Lisa Catapano-Friedman, Site 1646 413-281-0575 |
| Local Institution - 1644 | Seattle | Washington | 98122 | Site 1644 |
| Kingfisher Cooperative | Spokane | Washington | 99201 | David Greeley, Site 1654 509-458-7720 |
Find similar trials in Scottsdale, AZ
By condition
By specialty
Related Studies
- GeneMatch: A Program of the Alzheimer's Prevention Registry to Match Individuals to Studies Based on Apolipoprotein E (APOE) GenotypeEnrolling By Invitation · Banner Health · Phoenix, Arizona
- Neurologic Stem Cell Treatment StudyRecruiting · MD Stem Cells · Westport, Connecticut
- Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's DiseasePHASE4 · Recruiting · University of Texas at Austin · Austin, Texas
- Longitudinal Early-onset Alzheimer's Disease Study ProtocolRecruiting · Indiana University · Sun City, Arizona